Nutanix, Inc.
Congress has disclosed 1 buy and 5 sells of NTNX (Nutanix, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
6 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Joint · Joint Ownership LPL Account | 2025-01-13 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
64.4 | ↗ filing |
| Daniel Goldman | House | SELL | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-04-10 | 23 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Donna Shalala | House | SELL | Self | 2019-06-24 | 6 days | — | $1K–$15K | 86.8 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2019-05-28 | 15 days | — | $1K–$15K | 52.4 | ↗ filing |
| Nicholas Taylor | House | SELL | Spouse | 2019-03-25 | 0 days | — | $1K–$15K | 75.9 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2019-03-21 | 26 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in NTNX — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in NTNX, 1 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-12 | Sivaraman Rukmini | C-suite | SELL 10b5-1 | $13.4M | ↗ EDGAR |
| 2026-10-12 | Sivaraman Rukmini | C-suite | SELL 10b5-1 | $4.0M | ↗ EDGAR |
| 2026-10-09 | Sheppard Teresa Gayle | Director | SELL 10b5-1 | $206K | ↗ EDGAR |
| 2026-10-09 | Sheppard Teresa Gayle | Director | SELL 10b5-1 | $52K | ↗ EDGAR |
| 2026-10-07 | RAMASWAMI RAJIV | C-suite | SELL 10b5-1 | $5.6M | ↗ EDGAR |
| 2026-10-06 | RAMASWAMI RAJIV | C-suite | SELL 10b5-1 | $13.2M | ↗ EDGAR |
| 2026-10-06 | RAMASWAMI RAJIV | C-suite | SELL 10b5-1 | $10.7M | ↗ EDGAR |
| 2026-09-24 | Maner Tarkan | C-suite | SELL | $4.8M | ↗ EDGAR |
| 2026-09-17 | Sivaraman Rukmini | C-suite | SELL 10b5-1 | $2.7M | ↗ EDGAR |
| 2026-06-01 | Maner Tarkan | C-suite | SELL | $1.7M | ↗ EDGAR |
| 2026-05-29 | Maner Tarkan | C-suite | SELL | $974K | ↗ EDGAR |
| 2025-10-02 | Sheppard Teresa Gayle | Director | SELL 10b5-1 | $222K | ↗ EDGAR |
| 2025-10-02 | Sheppard Teresa Gayle | Director | SELL 10b5-1 | $46K | ↗ EDGAR |
| 2025-10-02 | RAMASWAMI RAJIV | C-suite | SELL 10b5-1 | $8.0M | ↗ EDGAR |
| 2025-10-02 | RAMASWAMI RAJIV | C-suite | SELL 10b5-1 | $3.0M | ↗ EDGAR |
| 2025-09-30 | Martin Brian | C-suite | SELL 10b5-1 | $784K | ↗ EDGAR |
| 2025-09-16 | Sivaraman Rukmini | C-suite | SELL 10b5-1 | $892K | ↗ EDGAR |
| 2025-06-26 | RAMASWAMI RAJIV | C-suite | SELL 10b5-1 | $144K | ↗ EDGAR |
| 2025-06-16 | Sivaraman Rukmini | C-suite | SELL 10b5-1 | $138K | ↗ EDGAR |
| 2025-06-16 | Sivaraman Rukmini | C-suite | SELL 10b5-1 | $15K | ↗ EDGAR |
| 2025-06-05 | de Groen Max Pieter | Director | SELL | $421.0M | ↗ EDGAR |
| 2025-06-05 | Gambale Virginia | Director | SELL | $546K | ↗ EDGAR |
| 2025-05-30 | GOMO STEVEN J | Director | SELL | $1.1M | ↗ EDGAR |
| 2025-05-13 | RAMASWAMI RAJIV | C-suite | SELL 10b5-1 | $4.8M | ↗ EDGAR |
| 2025-03-24 | RAMASWAMI RAJIV | C-suite | SELL 10b5-1 | $580K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-12 | Sivaraman Rukmini C-suite 10b5-1 | SELL | $13.4M |
| ◆ insider | 2026-10-12 | Sivaraman Rukmini C-suite 10b5-1 | SELL | $4.0M |
| ◆ insider | 2026-10-09 | Sheppard Teresa Gayle Director 10b5-1 | SELL | $206K |
| ◆ insider | 2026-10-09 | Sheppard Teresa Gayle Director 10b5-1 | SELL | $52K |
| ◆ insider | 2026-10-07 | RAMASWAMI RAJIV C-suite 10b5-1 | SELL | $5.6M |
| ◆ insider | 2026-10-06 | RAMASWAMI RAJIV C-suite 10b5-1 | SELL | $13.2M |
| ◆ insider | 2026-10-06 | RAMASWAMI RAJIV C-suite 10b5-1 | SELL | $10.7M |
| ◆ insider | 2026-09-24 | Maner Tarkan C-suite | SELL | $4.8M |
| ◆ insider | 2026-09-17 | Sivaraman Rukmini C-suite 10b5-1 | SELL | $2.7M |
| ◆ insider | 2026-06-01 | Maner Tarkan C-suite | SELL | $1.7M |
| ◆ insider | 2026-05-29 | Maner Tarkan C-suite | SELL | $974K |
| ◆ insider | 2025-10-02 | Sheppard Teresa Gayle Director 10b5-1 | SELL | $222K |
| ◆ insider | 2025-10-02 | Sheppard Teresa Gayle Director 10b5-1 | SELL | $46K |
| ◆ insider | 2025-10-02 | RAMASWAMI RAJIV C-suite 10b5-1 | SELL | $8.0M |
| ◆ insider | 2025-10-02 | RAMASWAMI RAJIV C-suite 10b5-1 | SELL | $3.0M |
| ◆ insider | 2025-09-30 | Martin Brian C-suite 10b5-1 | SELL | $784K |
| ◆ insider | 2025-09-16 | Sivaraman Rukmini C-suite 10b5-1 | SELL | $892K |
| ◆ insider | 2025-06-26 | RAMASWAMI RAJIV C-suite 10b5-1 | SELL | $144K |
| ◆ insider | 2025-06-16 | Sivaraman Rukmini C-suite 10b5-1 | SELL | $138K |
| ◆ insider | 2025-06-16 | Sivaraman Rukmini C-suite 10b5-1 | SELL | $15K |
| ◆ insider | 2025-06-05 | de Groen Max Pieter Director | SELL | $421.0M |
| ◆ insider | 2025-06-05 | Gambale Virginia Director | SELL | $546K |
| ◆ insider | 2025-05-30 | GOMO STEVEN J Director | SELL | $1.1M |
| ◆ insider | 2025-05-13 | RAMASWAMI RAJIV C-suite 10b5-1 | SELL | $4.8M |
FAQ Common questions
How much has Congress traded NTNX?
1 disclosed buys and 5 sells of NTNX (Nutanix, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade NTNX?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.